Back

Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes: residual and non-traditional risk Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Leonardo Luca Bavuso

S. Orsola-Malpighi Policlinic, Bologna (Italy)

7 More presentations in this session

Presentation thumbnail
Clinical characteristics and predictors of mortality in patients with refractory angina due to obstructive and non-obstructive chronic coronary syndromes: a contemporary retrospective cohort study.
Doctor K. Cheng (London, GB)
Abstract Slides Video
Presentation thumbnail
Biological age as a new risk factor for myocardial Infarction?
Miss I. Nemere (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Chest pain and cardiac troponin flat curve: six-month prognosis of a cohort of patients
Doctor P. Awamleh Garcia (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Proteomic characterization of human coronary artery reveals different pathological stages of atherosclerosis
Doctor X. Xu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Natural history of premature coronary artery disease : impact of residual atherosclerosis on long-term prognosis
Doctor G. Rahoual (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes: residual and non-traditional risk

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study
thumbnail
Congress Presentation
Association of LDL cholesterol levels and all cause mortality in a real world analysis using data from an international network
thumbnail
Congress Presentation
Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources